Cargando…
SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets
Combinatorial therapies have been recently proposed to improve the efficacy of anticancer treatment. The SynergyFinder R package is a software used to analyze pre-clinical drug combination datasets. Here, we report the major updates to the SynergyFinder R package for improved interpretation and anno...
Autores principales: | Zheng, Shuyu, Wang, Wenyu, Aldahdooh, Jehad, Malyutina, Alina, Shadbahr, Tolou, Tanoli, Ziaurrehman, Pessia, Alberto, Tang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801064/ https://www.ncbi.nlm.nih.gov/pubmed/35085776 http://dx.doi.org/10.1016/j.gpb.2022.01.004 |
Ejemplares similares
-
SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2017) -
DrugComb: an integrative cancer drug combination data portal
por: Zagidullin, Bulat, et al.
Publicado: (2019) -
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
por: Ianevski, Aleksandr, et al.
Publicado: (2020) -
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
por: Ianevski, Aleksandr, et al.
Publicado: (2022) -
Correction to ‘SynergyFinder 2.0: visual analytics of multi-drug combination synergies’
Publicado: (2022)